Published in Biochim Biophys Acta on June 24, 1998
Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin Drug Deliv (2010) 1.13
Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates. J Control Release (2011) 1.09
Light-Induced Content Release from Plasmon Resonant Liposomes. Adv Mater (2009) 1.09
Enzymatically degradable mussel-inspired adhesive hydrogel. Biomacromolecules (2011) 0.95
Wavelength-Selective Light-Induced Release from Plasmon Resonant Liposomes. Adv Funct Mater (2011) 0.90
Macropinocytosis is the major pathway responsible for DNA transfection in CHO cells by a charge-reversal amphiphile. Mol Pharm (2011) 0.89
Synthesis, characterization, and in vitro transfection activity of charge-reversal amphiphiles for DNA delivery. Bioconjug Chem (2011) 0.84
Enzyme-responsive nanomaterials for controlled drug delivery. Nanoscale (2014) 0.80
Enzyme-triggered PEGylated siRNA-nanoparticles for controlled release of siRNA. J RNAi Gene Silencing (2014) 0.79
siRNA Delivery by Stimuli-Sensitive Nanocarriers. Curr Pharm Des (2015) 0.76
Wind-driven upwelling in the Southern Ocean and the deglacial rise in atmospheric CO2. Science (2009) 5.36
Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance. J Biol Chem (2001) 3.86
Death due to bioterrorism-related inhalational anthrax: report of 2 patients. JAMA (2001) 3.55
DNA finger printing by oligonucleotide probes specific for simple repeats. Hum Genet (1986) 3.41
Missed appointments in general practice: retrospective data analysis from four practices. Br J Gen Pract (2001) 2.33
Src tyrosine kinase is a novel direct effector of G proteins. Cell (2000) 2.26
Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet (2001) 2.22
Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis (1993) 2.19
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res (2001) 2.15
Nosocomial infections due to Pseudomonas aeruginosa: review of recent trends. Rev Infect Dis (1984) 2.08
Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta (1985) 2.05
Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol (2001) 2.01
Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol Cell (2000) 1.77
An integrated approach utilizing artificial neural networks and SELDI mass spectrometry for the classification of human tumours and rapid identification of potential biomarkers. Bioinformatics (2002) 1.73
Prevalence of HLA sensitization in female apheresis donors. Transfusion (1999) 1.70
Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp Cell Res (1992) 1.68
Proteinuria in obstructive sleep apnea. Kidney Int (2001) 1.66
Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization. Mol Cell Biol (1999) 1.60
Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol). Biosci Rep (2002) 1.53
Characterization of surface properties of Vibrio cholerae. Infect Immun (1983) 1.50
A stroke unit in a district general hospital: the Greenwich experience. Br Med J (1979) 1.50
Strong constraints on the rare decays B(s)(0) → μ+ μ- and B0 → μ+ μ-. Phys Rev Lett (2012) 1.50
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents. Biochim Biophys Acta (1985) 1.49
Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol (1989) 1.48
Spread and persistence of Clostridium difficile spores during and after cleaning with sporicidal disinfectants. J Hosp Infect (2011) 1.48
Human estrogen receptor beta binds DNA in a manner similar to and dimerizes with estrogen receptor alpha. J Biol Chem (1997) 1.42
Determination of the X(3872) meson quantum numbers. Phys Rev Lett (2013) 1.42
Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen (2007) 1.41
Surma--a toxic cosmetic? J Pak Med Assoc (1988) 1.41
Influence of intravenous immunoglobulin therapy on autoantibody titres to BP Ag1 and BP Ag2 in patients with bullous pemphigoid. J Eur Acad Dermatol Venereol (2003) 1.40
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40
Comparison of long and short forms of the prolactin receptor on prolactin-induced milk protein gene transcription. Proc Natl Acad Sci U S A (1991) 1.40
Hairy canals and hair removal cream. Clin Otolaryngol (2008) 1.38
Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology (1996) 1.37
Novel multilayered lipid vesicles: comparison of physical characteristics of multilamellar liposomes and stable plurilamellar vesicles. Biochemistry (1985) 1.37
Does exclusion of enteral lipid assist remission in Crohn's disease? J Clin Gastroenterol (1993) 1.37
Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Res (1993) 1.37
Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells. J Biol Chem (1995) 1.36
Correlation of general anesthetic potency with solubility in membranes. Biochim Biophys Acta (1981) 1.35
Expression of prolactin and its receptor in human lymphoid cells. Mol Endocrinol (1992) 1.27
Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol (2001) 1.25
Amphotericin B-phospholipid interactions responsible for reduced mammalian cell toxicity. Biochim Biophys Acta (1992) 1.23
Role of Host Sensitivity to Ptr ToxA in Development of Tan Spot of Wheat. Phytopathology (2003) 1.22
Ecological analysis of ethnic differences in relation between tuberculosis and poverty. BMJ (1999) 1.22
The p38 MAPK pathway is required for cell growth inhibition of human breast cancer cells in response to activin. J Biol Chem (2001) 1.22
Relationship of growth temperature and thermotropic lipid phase changes in cytoplasmic and outer membranes from Escherichia coli K12. Biochim Biophys Acta (1979) 1.21
First observation of CP violation in the decays of B(s)0 mesons. Phys Rev Lett (2013) 1.21
The organization of the evolutionarily conserved GATA/GACA repeats in the mouse genome. Chromosoma (1986) 1.20
Phosphorylation of ERalpha at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ERalpha phosphorylation in breast cancer progression. Endocr Relat Cancer (2006) 1.20
In vitro and in vivo antifungal activity of amphotericin B lipid complex: are phospholipases important? Antimicrob Agents Chemother (1998) 1.19
The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer. Oncogene (2009) 1.19
Population Genetic Analysis of a Global Collection of Pyrenophora tritici-repentis, Causal Agent of Tan Spot of Wheat. Phytopathology (2005) 1.18
Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem (1995) 1.18
Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient. Biochim Biophys Acta (1998) 1.18
An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer (1998) 1.17
Expression of two forms of prolactin receptor in rat ovary and liver. Mol Endocrinol (1990) 1.17
Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2. J Biol Chem (1994) 1.17
Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ (2005) 1.17
Microarray coupled to quantitative RT-PCR analysis of androgen-regulated genes in human LNCaP prostate cancer cells. Oncogene (2009) 1.16
Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. Mol Endocrinol (1992) 1.16
A comparison of the antigen-presenting capabilities of class II MHC-expressing human lung epithelial and endothelial cells. Immunology (1997) 1.16
Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol (1995) 1.15
Regulation of ROMK1 channels by protein-tyrosine kinase and -tyrosine phosphatase. J Biol Chem (2000) 1.15
Human hybridoma lupus anticoagulants distinguish between lamellar and hexagonal phase lipid systems. J Biol Chem (1986) 1.14
Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem (1994) 1.14
False-positive and false-negative neck nodes. Head Neck Surg (1986) 1.13
Magic-angle spinning NMR studies of molecular organization in multibilayers formed by 1-octadecanoyl-2-decanoyl-sn-glycero-3-phosphocholine. Biophys J (1990) 1.13
Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures. Transbound Emerg Dis (2012) 1.11
Phospholipid in the hexagonal II phase is immunogenic: evidence for immunorecognition of nonbilayer lipid phases in vivo. Proc Natl Acad Sci U S A (1990) 1.11
The growth hormone/prolactin receptor family. Recent Prog Horm Res (1993) 1.11
Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity. Biochim Biophys Acta (1995) 1.10
On the nature of dilute aqueous cholesterol suspensions. J Lipid Res (1983) 1.10
Synexin-like proteins from human polymorphonuclear leukocytes. Identification and characterization of granule-aggregating and membrane-fusing activities. J Biol Chem (1987) 1.08
Valproate in the treatment of persistent chronic daily headache. An open label study. Headache (1991) 1.08
Tuberculoma of the brain: a series of 16 cases treated with anti-tuberculosis drugs. Int J Tuberc Lung Dis (2007) 1.07
Role of lipid polymorphism in pulmonary surfactant. Science (1996) 1.07
Novel inner monolayer fusion assays reveal differential monolayer mixing associated with cation-dependent membrane fusion. Biochim Biophys Acta (2000) 1.07
Complications following accidental administration of 1.5% glycine intravenously. Acta Anaesthesiol Scand (2008) 1.06
VEGF polymorphisms and severity of atherosclerosis. J Med Genet (2005) 1.05
Spermine as a modulator of membrane fusion: interactions with acidic phospholipids. Biochemistry (1986) 1.05
Protein-tyrosine phosphatase 1D modulates its own state of tyrosine phosphorylation. J Biol Chem (1995) 1.04
Diabetes UK funded surveys of the structural provision of primary care diabetes services in the UK. Diabet Med (2002) 1.03
Modulatory effects of heparin and short-length oligosaccharides of heparin on the metastasis and growth of LMD MDA-MB 231 breast cancer cells in vivo. Br J Cancer (2007) 1.03
Adapter function of protein-tyrosine phosphatase 1D in insulin receptor/insulin receptor substrate-1 interaction. J Biol Chem (1995) 1.03
Intracrine and autocrine effects of basic fibroblast growth factor in vascular smooth muscle cells. J Mol Cell Cardiol (1997) 1.02
Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation. Immunology (1997) 1.02
Genetic study of the CD36 gene in a French diabetic population. Diabetes Metab (2004) 1.02
Antioxidant micronutrients in children with thalassaemia in Egypt. East Mediterr Health J (2004) 1.01
Re-186(Sn) HEDP for treatment of multiple metastatic foci in bone: human biodistribution and dosimetric studies. Radiology (1988) 1.01
Behavior of amphotericin B lipid complex in plasma in vitro and in the circulation of rats. Antimicrob Agents Chemother (1997) 1.00
Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells. Hepatology (1996) 1.00
Does vitamin D deficiency account for ethnic differences in tuberculosis seasonality in the UK? Ethn Health (1998) 1.00
Genetic and Physical Mapping of a Gene Conditioning Sensitivity in Wheat to a Partially Purified Host-Selective Toxin Produced by Stagonospora nodorum. Phytopathology (2004) 0.99
Leucocyte chemotaxis: Examination of mitogen-activated protein kinase and phosphoinositide 3-kinase activation by Monocyte Chemoattractant Proteins-1, -2, -3 and -4. Clin Exp Immunol (2002) 0.99
Characteristics of EGFR family-mediated HRG signals in human ovarian cancer. J Cell Biochem (1999) 0.99
Characterization of the role of the stimulatory magnesium of Escherichia coli porphobilinogen synthase. Biochemistry (1995) 0.99
Hydrolysis of short acyl chain inositol lipids by phospholipase C-delta 1. J Biol Chem (1993) 0.98
Distinguishing plasma lupus anticoagulants from anti-factor antibodies using hexagonal (II) phase phospholipids. Thromb Haemost (1989) 0.98
Complete nucleotide sequence of the genomic ovine beta-lactoglobulin gene. Nucleic Acids Res (1988) 0.97